Sandra Yamile Saavedra
Grupo México
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sandra Yamile Saavedra.
Enfermedades Infecciosas Y Microbiologia Clinica | 2013
Aura Lucía Leal; Jorge Alberto Cortés; Gerson Arias; María Victoria Ovalle; Sandra Yamile Saavedra; Giancarlo Buitrago; Javier Antonio Escobar; Betsy Esperanza Castro
INTRODUCTION Urinary tract infection (UTI) is a common disease in the community, and a matter of concern due to the increasing resistance of microorganisms to first line antibiotics and the emergence of multiresistant strains producing extended spectrum beta lactamases (ESBL) in the community. METHODS An analytical case-control study was conducted over twelve months in 9 hospitals in Colombia. We collected isolates of E. coli, Klebsiella spp. and Proteus spp. from patients with community-onset UTI. The presence of ESBL, AmpC and KPC beta-lactamases were characterized by microbiological and molecular methods. The aim of this study was to determine factors related to the presence of these mechanisms of the resistance to third generation cephalosporins. RESULTS A total of 325 isolates (287 E. coli, 29 Klebsiella spp. and 9 Proteus spp.) were included. The most frequent comorbidities among the patients were hypertension (n=82; 25.2%) and diabetes mellitus (n=68; 20.9%). Previous use of antimicrobials was found in 23% of patients, and 29% had a previous UTI. Resistance to third and fourth generation cephalosporins varied between 3.4% and 6.3% in E. coli and between 6.9% and 17.8% in K. pneumoniae. Seven (2.4%) CTX-M-15 ESBL-producing E. coli isolates were detected; four of them belonged to ST 131 clone. In K. pneumoniae we detected three KPC-3 carbapenemases (10.3%). CONCLUSIONS This study confirms the emergence of resistance to third generation cephalosporins enterobacteriaceae as a cause of community-onset UTI. We emphasize the presence of ST 131 clone and KPC carbapenemases circulating in Colombia outside the hospital environment.
Genome Announcements | 2017
R. Alejandro Marquez-Ortiz; Leanne Haggerty; Eby M. Sim; Carolina Duarte; Betsy Castro-Cardozo; Mauricio Beltrán; Sandra Yamile Saavedra; Natasha Vanegas; Nicola K. Petty
ABSTRACT Providencia rettgeri is an opportunistic bacterial pathogen of clinical significance due to its association with urinary tract infections and multidrug resistance. Here, we report the first complete genome sequence of P. rettgeri. The genome of strain RB151 consists of a 4.8-Mbp chromosome and a 108-kbp blaNDM-1-positive plasmid.
Antimicrobial Agents and Chemotherapy | 2017
Sandra Yamile Saavedra; Lorena Diaz; Magdalena Wiesner; Adriana Correa; Stefany Alejandra Arévalo; Jinnethe Reyes; Andrea Melissa Hidalgo; Elsa De La Cadena; Marcela Perenguez; Lucy Angeline Montaño; Javier Ardila; Rafael Rios; María Victoria Ovalle; Paula Lucía Díaz; Paola Porras; Maria Virginia Villegas; Cesar A. Arias; Mauricio Beltrán; Carolina Duarte
ABSTRACT Polymyxins are last-resort antimicrobial agents used to treat infections caused by carbapenem-resistant Enterobacteriaceae. Due to the worldwide dissemination of polymyxin resistance in animal and human isolates, we aimed to characterize polymyxin resistance associated with the presence of mcr-1 in Enterobacteriaceae and nonfermenter Gram-negative bacilli, using isolates collected retrospectively in Colombia from 2002 to 2016. A total of 5,887 Gram-negative clinical isolates were studied, and 513 were found to be resistant to the polymyxins. Susceptibility to colistin was confirmed by broth microdilution for all mcr-1-positive isolates, and these were further subjected to whole-genome sequencing (WGS). The localization of mcr-1 was confirmed by S1 pulsed-field gel electrophoresis (S1-PFGE) and CeuI-PFGE hybridization. Transferability was evaluated by mating assays. A total of 12 colistin-resistant isolates recovered after 2013 harbored mcr-1, including 8 Escherichia coli, 3 Salmonella enterica serovar Typhimurium, and 1 Klebsiella pneumoniae isolate. E. coli isolates were unrelated by PFGE and belonged to 7 different sequence types (STs) and phylogroups. S. Typhimurium and K. pneumoniae isolates belonged to ST34 and ST307, respectively. The mcr-1 gene was plasmid borne in all isolates but two E. coli isolates which harbored it on the chromosome. Conjugation of mcr-1 was successful in 8 of 10 isolates (8.2 × 10−5 to 2.07 × 10−1 cell per recipient). Plasmid sequences showed that the mcr-1 plasmids belonged to four different Inc groups (a new IncP-1 variant and the IncFII, IncHI1, and IncH families). Our results indicate that mcr-1 is circulating in clinical isolates of colistin-resistant Enterobacteriaceae in Colombia and is mainly harbored in transferable plasmids.
Genome Announcements | 2017
Sandra Yamile Saavedra; Diego Prada-Cardozo; Verónica Rincón; Hermes Pérez-Cardona; Andrea Melissa Hidalgo; María Nilse González; María Teresa Reguero; Emilia María Valenzuela de Silva; José Ramón Mantilla; Laurent Falquet; Emiliano Barreto-Hernández; Carolina Duarte
ABSTRACT Colombian Acinetobacter baumannii strain ST920 was isolated from the sputum of a 68-year-old male patient. This isolate possessed blaOXA-72 and blaOXA-255-like genes. The assembled genome contained 4,104,098 pb and 38.79% G+C content. This is the first case reported of the coproduction (blaOXA-72 and blaOXA-255-like) of carbapenem-hydrolyzing class D β-lactamases (CHDLs) in Acinetobacter baumannii.
Biomedica | 2017
María Victoria Ovalle; Sandra Yamile Saavedra; María Nilse González; Andrea Melissa Hidalgo; Carolina Duarte; Mauricio Beltrán
INTRODUCTION The Colombian National Antimicrobial Resistance Monitoring System for the surveillance of healthcare-associated infections was set up to meet this problem in the third quarter of 2012. OBJECTIVE To describe resistance profiles and laboratory-based surveillance based on the information collected by the System. MATERIALS AND METHODS We conducted a retrospective and descriptive study of the information notified to the Colombian Public Health Surveillance System (Sivigila), and in the Whonet databases covering the period from July 2012 to December 2014 provided by the primary data-generating units in the country, as well as laboratory surveillance results from 1,642 phenotypic and genotypic tests on carbapenemase isolates (927 from Enterobacteriaceae, 614 from Pseudomonas spp. and 101 from Acinetobacter spp.). RESULTS There was a significant increase in Escherichia coli resistance to third-generation cephalosporins (reaching 26.3% in ICUs and 22.5% in other hospital wards), and Klebsiella pneumoniae resistance to ertapenem also increased (reaching 14.6% in ICUs). Acinetobacter baumannii carbapenem resistance exceeded 50% in ICUs whereas Pseudomonas aeruginosa had lower carbapenem resistance (38.8%). KPC (n = 574) and NDM (n=57) were the most frequently occurring carbapenemases in Enterobacteriaceae, VIM (n=229) and KPC (n=114) in P. aeruginosa, and OXA-23 in A. baumannii (n=87); several carbapenemase combinations were identified, KPC + VIM being the most common in Pseudomonas spp. and Enterobacteriaceae. CONCLUSION The data from the surveillance of healthcare-associated infections revealed significant carbapenem resistance profiles and antimicrobial resistance mechanisms circulating in Colombian healthcare institutions.
Biomedica | 2014
Edna Catering Rodríguez; Sandra Yamile Saavedra; Aura Lucía Leal; Carlos Álvarez; Narda Olarte; Alberto Valderrama; Sonia Isabel Cuervo; Javier Antonio Escobar
Biomedica | 2014
Sandra Yamile Saavedra; Carolina Duarte; María Nilse González; María Elena Realpe
Biomedica | 2017
María Victoria Ovalle; Sandra Yamile Saavedra; María Nilse González; Andrea Melissa Hidalgo; Carolina Duarte; Mauricio Beltrán
Biomedica | 2015
Jaime Moreno; Olga Sanabria; Sandra Yamile Saavedra; Karina Rodríguez; Carolina Duarte
Retos y Oportunidades en la Ciencia del Suelo : VI Congreso Ibérico de la Ciencia del Suelo, Santiago de Compostela del 22 al 25 de junio de 2014, 2014, ISBN 978-84-8408-769-4, págs. 133-136 | 2014
J. Aboal; Sandra Yamile Saavedra; J. M. Hernández Moreno